Takehisa Nakajima

Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin

Kimiko Makino, Takehisa Nakajima, Mitsuhiko Shikamura et al. · Colloids and Surfaces B Biointerfaces · 2004 · 142 citations

Inflammation, Nanomedicine, Cell-based Drug Delivery +10

Delivery of rifampicin–PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis

Keiji Hirota, Taizo Hasegawa, Takehisa Nakajima et al. · Journal of Controlled Release · 2009 · 126 citations

Nanomedicine, Pulmonary Tuberculosis, Medicine +8

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

Keishiro Tomoda, Takumi Ohkoshi, Keiji Hirota et al. · Colloids and Surfaces B Biointerfaces · 2009 · 93 citations

Nanoparticles, Nanomedicine, Chemical Engineering +8

Selective delivery of rifampicin incorporated into poly(dl-lactic-co-glycolic) acid microspheres after phagocytotic uptake by alveolar macrophages, and the killing effect against intracellular Mycobacterium bovis Calmette–Guérin

Aya Yoshida, Makoto Matumoto, Hiroyuki Hshizume et al. · Microbes and Infection · 2006 · 61 citations

Inflammation, Microbial Pathogens, Antibiotics +14

Preparation and properties of inhalable nanocomposite particles: Effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles

Keishiro Tomoda, Takumi Ohkoshi, Takehisa Nakajima et al. · Colloids and Surfaces B Biointerfaces · 2008 · 61 citations

Materials Science, Nanomedicine, Chemical Engineering +9